Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease
The American heart journal, 2013-12, Vol.166 (6), p.983-989.e7 [Peer Reviewed Journal]Mosby, Inc. ;2013 Mosby, Inc. ;2013. ;Copyright Elsevier Limited Dec 2013 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2013.09.003 ;PMID: 24268212 ;CODEN: AHJOA2
Full text available